Isolinderalactone

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Isolinderalactone 

Isolinderalactone 通过抑制内皮细胞 VEGFR2 活化，抑制人胶质母细胞瘤的生长和血管生成活性。Isolinderalactone 抑制Bcl-2， survivin和XIAP的表达，增加 cleaved caspase-3 的水平。

Isolinderalactone

Isolinderalactone Chemical Structure

CAS No. : 957-66-4

规格 是否有货
5 mg 询价
10 mg 询价
25 mg 询价

* Please select Quantity before adding items.

生物活性

Isolinderalactone suppresses human glioblastoma growth and angiogenic activity through the inhibition of VEGFR2 activation in endothelial cells[1]. Isolinderalactone suppresses the expression of B-cell lymphoma 2 (Bcl-2), survi

IC50 & Target

VEGFR2

 

Bcl-2

 

分子量

244.29

Formula

C15H16O3
CAS 号

957-66-4
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Park JH, et al. Isolinderalactone suppresses human glioblastoma growth and angiogenic activity in 3D microfluidic chip and in vivo mouse models. Cancer Lett. 2020;478:71-81.

    [2]. Hwang JY, et al. Isolinderalactone regulates the BCL-2/caspase-3/PARP pathway and suppresses tumor growth in a human glioblastoma multiforme xenograft mouse model. Cancer Lett. 2019;443:25-33.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务